Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | US

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
SG Company A consulting firm for 360° communication, marketing, and event services for businesses.	Italy	SGC
SHIKIGAKU.Co.,Ltd. Drives organizational growth with a unique management theory for diverse corporate clients.	Japan	7049
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. A contract research organization providing preclinical and clinical services for medical industries.	Japan	2395
SHIP HEALTHCARE HOLDINGS, INC. A healthcare support company for medical facilities, offering consulting, equipment, and supplies.	Japan	3360
Silence Therapeutics plc Develops RNAi therapies that silence disease genes for rare and underserved conditions.	United States of America	SLN
SillaTextile Italian consultancy for fabric design and development for high-end apparel brands.	South Korea	001000
Simulations Plus, Inc. Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.	United States of America	SLP
Skeena Resources Ltd Revitalizing past-producing mines for gold, silver, and critical metals in BC's Golden Triangle.	United States of America	SKE
SLSBio(Specialty Lab Solution Bio) Co., Ltd Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.	South Korea	246250
SMN Corporation A marketing tech firm providing AI-powered, data-driven solutions for advertisers and agencies.	Japan	6185